Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
Takeda Pharmaceutical Co ADR (NYSE: TAK) closed the day trading at $14.19 down -1.18% from the previous closing price of $14.36. In other words, the price has decreased by -$1.18 from its previous closing price. On the day, 5.38 million shares were traded.
Ratios:
For a better understanding of TAK, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 17.34 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 8.96. For the most recent quarter (mrq), Quick Ratio is recorded 0.52 and its Current Ratio is at 1.01. In the meantime, Its Debt-to-Equity ratio is 0.65 whereas as Long-Term Debt/Eq ratio is at 0.57.
On March 16, 2023, BofA Securities Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $20.
Cowen Upgraded its Market Perform to Outperform on July 19, 2022, whereas the target price for the stock was revised from $21 to $24.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 23 ’24 when Giles Richard Platford bought 19,073 shares for $14.94 per share.
Valuation Measures:
As of this moment, Takeda’s Price-to-Earnings (P/E) ratio for their current fiscal year is 65.30, and their Forward P/E ratio for the next fiscal year is 23.73. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.53. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.49 while its Price-to-Book (P/B) ratio in mrq is 0.96.
Stock Price History:
Over the past 52 weeks, TAK has reached a high of $15.43, while it has fallen to a 52-week low of $12.57. The 50-Day Moving Average of the stock is -4.68%, while the 200-Day Moving Average is calculated to be 0.30%.
Shares Statistics:
A total of 3.15B shares are outstanding, with a floating share count of 3.15B. Insiders hold about 0.02% of the company’s shares, while institutions hold 5.13% stake in the company.
